Last updated on November 2017

Fatty Liver (Nonalcoholic Steatohepatitis - NASH)


Brief description of study

Fatty Liver (Nonalcoholic Steatohepatitis - NASH)

Detailed Study Description

Wake Research Associates is currently enrolling volunteers in a research study of the safety and effectiveness of an investigational drug for excess fat in the liver (NASH*).

Clinical Study Identifier: TX11341

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Wake Research Associates

Wake Research Associates
Raleigh, NC USA
  Connect »